CoChat

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

Thomopoulos, Costas, Parati, Gianfranco, Zanchetti, Alberto · 2014 · Journal of Hypertension

The DOI matches its Crossref record; 89 of the 93 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Antihypertensive treatment is based on randomized controlled trials (RCTs) started since 1966. Meta-analyses comprehensive of all RCTs but limited to RCTs investigating blood pressure (BP) lowering in hypertensive patients are lacking. OBJECTIVES: Two clinical questions were investigated: the extent of different outcome reductions by BP lowering in hypertensive patients, and the proportionality of outcome reductions to SBP, DBP, and pulse pressure (PP) reductions. METHODS: PubMed between 1966 and December 2013 (any language), Cochrane Collaboration Library and previous overviews were used as data sources for identifying and selecting all RCTs comparing the antihypertensive drugs with placebo or less intense BP lowering (intentional BP-lowering RCTs); comparing BP-lowering drugs with placebo without BP-lowering intention, but with BP difference (nonintentional BP-lowering RCTs); and enrolling at least 40% hypertensive patients. RCTs on acute myocardial infarction, heart failure, acute stroke, and dialysis were excluded. RCT quality was assessed by scoring. Risk ratios and 95% confidence interval (CI), standardized to 10/5 mmHg SBP/DBP reduction, of seven fatal and nonfatal outcomes were calculated (random-effects model). The relationships of different outcome reductions to SBP, DBP, and PP reductions were investigated by meta-regressions. RESULTS: A total of 68 RCTs (245,885 individuals) were eligible, of which 47 (153,825 individuals) were 'intentional' RCTs. All outcomes were reduced (P < 0.001) by BP lowering, stroke [-36% (-29, -42)], and heart failure [-43% (-28, -54)] to a greater extent, with smaller reductions for coronary events [coronary heart disease (CHD): -16% (-10, -21)], cardiovascular [-18% (-11, -24)], and all-cause mortality [-11% (-5, -16)]. Absolute risk reductions were 17 (14, 20) strokes, 28 (19, 35) cardiovascular events, and 8 (4, 12) deaths prevented every 1000 patients treated for 5 years. Logarithmic risk ratios were related to SBP, DBP, and PP reductions (P = 0.001-0.003) for stroke and composite cardiovascular events, but not for CHD. CONCLUSION: Meta-analyses of all BP-lowering RCTs involving hypertensive patients provide precise estimates of benefits (larger for stroke and heart failure, but also significant for CHD and mortality). Absolute risk reductions are substantial. Relationships of logarithmic risk ratios with BP reductions imply risk reduction increases progressively to a smaller extent the larger the BP reduction.

Overview

Integrity signals

Registry

Crossref · 10.1097/hjh.0000000000000378

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 89 references

Research works printed but not linked: 1

  1. 1995, Poststroke antihypertensive treatment study. A preliminary result., Chin Med J (Engl), 108, 710

Cited by

See all 459

Metadata

Authors
Thomopoulos, C., Parati, G., & Zanchetti, A.
Affiliations
University of Milan (IT)
Corresponding author
Zanchetti, Alberto
Venue
Journal of Hypertension
Published
2014-12
Volume
32
Issue
12
Pages
2285-2295
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2323393982
Cited by
388
References
93
Citations by year
2026: 23 · 2025: 29 · 2024: 38 · 2023: 38 · 2022: 49 · 2021: 48 · 2020: 29 · 2019: 34 · 2018: 24 · 2017: 25 · 2016: 32 · 2015: 16 · 2014: 3
FWCI
4.08
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Funders
  • Istituto Auxologico Italiano
  • Hellenic Society of Cardiology
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
hypertension, blood pressure reduction, antihypertensive drugs, stroke prevention, heart failure, cardiovascular events, all-cause mortality, coronary artery disease, systolic blood pressure, diastolic blood pressure, pulse pressure, risk mitigation, meta-regression, cardiovascular risk prevention
MeSH terms
Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Coronary Artery Disease, Humans, Hypertension, Regression Analysis, Incidence, Randomized Controlled Trials as Topic, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. https://app.cochat.ai/papers/10.1097/hjh.0000000000000378
The paper
Thomopoulos, C., Parati, G., & Zanchetti, A. (2014). Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000000378

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.